991 patents currently held
13 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
2 more records may belong here and await a decision; they are not counted.
The next term ends in Dec 2026. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
111
Ending by 2030
Dec 2026
Next term end
910
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends no later than Aug 2027 · Medium confidence
Also notable
Ends Nov 2028 · High confidence
Also notable
Ends no later than Aug 2028 · Medium confidence
Rare Cell Analysis Using Sample Splitting and DNA Tags
US 8,372,584
Cited by 397 later US patents, top 1% of utility patents granted in 2013 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2027. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
Methods for the Diagnosis of Fetal Abnormalities
US 8,137,912
The most cited patent in this portfolio, cited by 504 later US patents, top 1% of utility patents granted in 2012 in our data. Protection runs to 2028.
Aqueous Carbon Nanotube Applicator Liquids and Methods for Producing Applicator Liquids Thereof
US 7,666,382
Cited by 109 later US patents, top 10% of utility patents granted in 2010 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2028. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 5 fees due Nov 21 to 30, 2026 · next Nov 21
- 14 fees due Dec 2 to 30, 2026 · next Dec 2
- 16 fees due Jan 2 to 25, 2027 · next Jan 2
- 18 fees due Feb 6 to 28, 2027 · next Feb 6
- 13 fees due Mar 3 to 24, 2027 · next Mar 3
- 18 fees due Apr 1 to 30, 2027 · next Apr 1
- 19 fees due May 3 to 28, 2027 · next May 3
- 20 fees due Jun 1 to 30, 2027 · next Jun 1
- 20 fees due Jul 7 to 30, 2027 · next Jul 7
- 24 fees due Aug 4 to 25, 2027 · next Aug 4
- 24 fees due Sep 1 to 30, 2027 · next Sep 1
- 28 fees due Oct 2 to 30, 2027 · next Oct 2
- 15 fees due Nov 5 to 14, 2027 · next Nov 5
Recent changes
- Sep 18Assignment recorded on 1 record: Yonemaru, Hiroyuki to Zeon Corporation Recorded Sep 18, 2026, executed Sep 9, 2026. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76519, frame 909.
- 27 of the patents on this record were granted since Aug 19, 2026
- 28 terms have ended since Aug 19, 2026
What they patent
The 5 largest of its 910 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Aqueous Carbon Nanotube Applicator Liquids and Methods for Producing Applicator Liquids Thereof | 24 in force | to Oct 2034 |
| Rare Cell Analysis Using Sample Splitting and DNA Tags | 7 in force | to Mar 2028 |
| Methods for Preparing Therapeutically Active Cells Using Microfluidics | 5 in force | to Oct 2037 |
| Foldable solar panel | 4 in force | to May 2035 |
| Methods for the Diagnosis of Fetal Abnormalities | 4 in force | to Nov 2028 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,956,562 | Devices And Method For Enrichment And Alteration Of Cells And Other Particles In force · High confidence | In force | High confidence | |
| US 7,719,645 | Optically Anisotropic Body and Liquid Crystal Display In force · High confidence | In force | High confidence | |
| US 7,951,981 | Process for Producing Perfluoroalkyne Compound In force · High confidence | In force | High confidence | |
| US 7,824,043 | Reflection Preventing Layered Product and Optical Member In force · High confidence | In force | High confidence | |
| US 9,017,942 | Rare Cell Analysis Using Sample Splitting and DNA Tags In force · Medium confidence | In force | Medium confidence | |
| US 9,347,100 | Rare Cell Analysis Using Sample Splitting and DNA Tags In force · Medium confidence | In force | Medium confidence | |
| US 10,435,751 | Methods for the Diagnosis of Fetal Abnormalities In force · High confidence | In force | High confidence | |
| US 10,704,090 | Fetal Aneuploidy Detection by Sequencing In force · High confidence | In force | High confidence | |
| US 11,261,492 | Methods for the Diagnosis of Fetal Abnormalities In force · High confidence | In force | High confidence | |
| US 11,378,498 | Diagnosis of Fetal Abnormalities Using Polymorphisms Including Short Tandem Repeats In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 991: 13 patents in force now held by others · 390 patents ended · 274 applications pending · 653 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.